1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Rare disease AI/ML for Precision Integrated Diagnostics (RAPID) is sponsored by Advanced Research Projects Agency for Health (ARPA-H). The RAPID program seeks to revolutionize rare disease diagnosis by developing and validating AI-enabled diagnostic support systems. It will integrate fragmented data to build a large dataset of longitudinal rare disease patient data for training AI algorithms.
The program will also fund partnerships with patient advocacy groups to ensure a patient-centered approach to data collection and tool development.
Get alerted about grants like this
Get emailed when new opportunities from “Advanced Research Projects Agency for Health (ARPA-H)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Performer teams are invited to submit proposals across three technical areas: massive-scale rare disease data collection, discovery of novel diagnostic indicators, and a sustainable platform for AI-driven diagnostic tools. Partnerships with patient advocacy groups are also encouraged. Confirm the full requirements in the official notice before applying.
Rare disease AI/ML for Precision Integrated Diagnostics (RAPID) is funded by Advanced Research Projects Agency for Health (ARPA-H). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Innovation Grant is a grant from the Delta Dental of Arizona Foundation that funds nonprofit organizations pursuing unique, high-impact projects that improve health and wellness in Arizona communities. This two-year award supports original initiatives with measurable real-world impact, including programs serving underserved and uninsured populations through oral health education, disease prevention, and nutritional access. Projects must demonstrate the potential to make a meaningful difference in the community and stand apart from conventional approaches. Eligible applicants are Arizona-based nonprofit organizations. Awards total $100,000 per recipient over two years. The 2026 application cycle closed October 16, 2025, with recipients notified in late 2025 and funding made available shortly after.
ARPA-H's 2026 SBIR/STTR BAA opens seven transformative health topics with $600K Phase I and $3.5M Phase II contracts — non-dilutive, milestone-driven money. The July 10 Solution Summary gate decides who ever gets to pitch. Here's how the ARPA-H model differs from NIH and how small health-tech firms actually get through the funnel.
Read articleARPA-H's FY2026 SBIR/STTR solicitation closes its Solution Summary stage July 10, with seven named topics spanning women's health, autoimmune diagnostics, toxin removal, and neurosurgical robotics. Awards run up to $600K for Phase I and $3.5M for Phase II — but they are contracts, not grants, and the four-to-six-page summary is the gate that filters out most applicants. Here is how ARPA-H's model actually works and how to win the first stage.
Read articleARPA-H's FY2026 SBIR/STTR solicitation opens with a Solution Summary due July 10, 2026, then a Technical Oral Presentation by September 9 for those invited. Awards run up to $600K (Phase I) and $3.5M (Phase II), with Direct-to-Phase-II and Fast Track options across seven health topic areas. Here is how the two-step, pitch-driven process differs from NIH SBIR — and how to win the first gate.
Read article